Pereiti į pagrindinį turinį
Home
language-selector-globe Lithuania | lt
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Lithuania
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Apie mus 
      • Novartis Lietuvoje 
      • Strategija 
      • Įvairovė ir įtrauktis 
      • Žmonės ir kultūra 
      • Produktai 
      • Susisiekite su mumis 
      Apie mus Apie mus
    • Pacientai ir slaugytojai 
      • Novartis įsipareigojimas pacientams ir slaugytojams 
      • Terapinės sritys 
      • Produktai 
      • Pranešti apie nepageidaujamą reiškinį 
        • Pranešti apie įtariamą nepageidaujamą reiškinį 
      • Parama pacientų organizacijoms 
      Gydytojas tikrina paciente su stratoskopu Pacientai ir slaugytojai
    • Sveikatos priežiūros specialistai 
      • Novartis interneto svetainė sveikatos priežiūros specialistams 
      • Produktai 
      • Novartis vystomų produktų asortimentas 
      • Pranešti apie nepageidaujamą reiškinį 
      • Bendradarbiavimas su sveikatos priežiūros specialistais 
      • Novartis klinikiniai tyrimai 
      Gydytojai kalbasi ligonineje Sveikatos priežiūros specialistai
    • Aplinkos apsauga, socialinė atsakomybė ir valdysena (ASV) 
      • Etika, rizikos valdymas ir atitiktis 
      • Prieinamumas 
      • Aplinkos tvarumas 
      • Pasaulinė sveikatos apsauga 
      • Etiškas elgesys 
        • Etikos kodeksas 
    • Naujienos 
      • Naujienų archyvas 
      • Susisiekite su mumis 
      A photo of people in a meeting hall Naujienos
    • Karjera 
      • Karjeros paieška 
      • Mūsų komandos 
      • Asmeninis augimas 
      • Jaunieji talentai 
      • Kaip mes dirbame 
      • Darbuotojų gerovė 
      • Įvairovė ir įtrauktis 
      • Apdovanojimai ir pripažinimas 
      Karjera Karjera
    • Koronavirusas 
      coronavirus-microscope-image Koronavirusas
    Vilniaus panorama Pagrindinis puslapis
  1. Pagrindinis puslapis
  2. Karjera
  3. Karjeros paieška
  • Sort by Sort ascending
  • Darbo pavadinimas
  • Svetainė
  • Vieta
  • Padalinys
  • Veikla
  • Functional Area Sort ascending
  • Paskelbimo data
Darbo pavadinimas Svetainė Vieta Padalinys Veikla Functional Area Sort ascending Paskelbimo data
Alternant CHEF DE PROJET (Maladie de Verneuil/Urticaire Chronique) Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others Gegužė 28, 2024
APPRENTI(E) COORDINATEUR FORMATION (H/F) Huningue France Operations Innovative Medicines Others Gegužė 31, 2024
APPRENTI(E) ANIMATEUR SSE (H/F) Huningue France Operations Innovative Medicines Others Bir 10, 2024
HR Data Analyst & Communication H/F en Alternance Paris Headquarter (Novartis Pharma S.A.S.) France People & Organization Innovative Medicines Others Lie 04, 2024
Analyst Stratégique H/F) en Stage Rueil-Malmaison France International Innovative Medicines Others Rugp 19, 2024
Lehrling Chemieverfahrenstechnik Schaftenau Austria Operations Innovative Medicines Others Rug 12, 2024
Juristisches Volontariat – Novartis Corporate Functions Basel (City) Switzerland Legal Corporate Others Rug 26, 2024
Werkstudent (w/m/d) im Bereich Medical Statistics / Epidemiology / Health Statistics Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Others Rug 30, 2024
Legal Trainee / Rechtsreferendar (m/f/d) in der Rechtsanwaltsstation oder im Pflichtwahlpraktikum Munich (Novartis Business Services GmbH) Germany Legal CTS Others Spa 04, 2024
Pharmaziepraktikant (w/m/d) im Quality Management ab Mai 2025 Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany Operations Innovative Medicines Others Spa 09, 2024
Duales Studium (Bachelor) BWL Industrie Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany People & Organization Innovative Medicines Others Spa 10, 2024
Duales Studium (Bachelor) BWL Gesundheitsmanagement Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany People & Organization Innovative Medicines Others Spa 10, 2024
QA Compliance Postgraduate Stein Aargau Switzerland Operations Innovative Medicines Others Spa 14, 2024
Postgraduate Program in TRD-Biologics Basel (City) Switzerland Development Innovative Medicines Others Spa 15, 2024
Lehrling Elektrotechnik Schaftenau Austria Operations Innovative Medicines Others Rug 11, 2024
Lehre Labortechnik Schaftenau Austria Operations Innovative Medicines Others Rug 11, 2024
Lehrling Mechatronik Schaftenau Austria Operations Innovative Medicines Others Rug 11, 2024
Long term Finance Internship İstanbul Kavacık Turkey Finance Innovative Medicines Others Rug 10, 2024
Chef de Projet Omnicanal – Apprenti H/F Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others Lie 04, 2024
Next Generation Scientist 2025 Basel (City) Switzerland Biomedical Research Innovative Medicines Others Spa 01, 2024
Legal Trainee - Novartis Operations Basel (City) Switzerland Operations CTS Others Spa 15, 2024
Digital Project Intern Rotkreuz (Office-Based) Switzerland International Innovative Medicines Others Spa 15, 2024
Legal Trainee - Legal Procurement, Data/Digital & IT Basel (City) Switzerland Legal CTS Others Spa 10, 2024
Postdoc Patient-Centered Outcomes Basel (City) Switzerland Development Innovative Medicines Others Spa 09, 2024
Supply Chain Graduate Program Associate - UAE National Dubai Utd.Arab Emir. Operations Innovative Medicines Others Spa 14, 2024
ERP Assurance Senior Consultant-2 INSURGENTES Mexico Finance CTS Audit & Finance Rugp 20, 2024
FRA Technical Accounting & Special Projects APMA Selangor Malaysia Operations CTS Audit & Finance Rugp 22, 2024
Business Planning and Analysis Manager, Novartis Technical Operations INSURGENTES Mexico Finance Innovative Medicines Audit & Finance Rugp 22, 2024
Investor Relations Executive Director East Hanover USA Finance Corporate Audit & Finance Rugp 28, 2024
Senior Financial Analyst - Digital Finance Hyderabad (Office) India Finance Corporate Audit & Finance Spa 16, 2024
Manager - FC&C Hyderabad (Office) India Finance CTS Audit & Finance Spa 16, 2024
Treasury Cash Management Payment Specialist INSURGENTES Mexico Finance CTS Audit & Finance Spa 16, 2024
Financial IT Compliance Senior Specialist London (The Westworks) Czech Republic Finance CTS Audit & Finance Spa 17, 2024
Financial IT Compliance Manager London (The Westworks) Czech Republic Finance CTS Audit & Finance Spa 17, 2024
Vodja Finančne skladnosti in kontrol Slovenija (m/ž/d) / Financial Control and Compliance Lead Slovenia (m/f/d) Ljubljana Slovenia Finance CTS Audit & Finance Spa 17, 2024
RLT Sasayama_Associate_Finance Business Planning and Analysis Sasayama Japan Finance Innovative Medicines Audit & Finance Rug 17, 2024
Senior Manager ERP Assurance Hyderabad (Office) India Finance CTS Audit & Finance Rug 23, 2024
R2R Specialist - Inventory Selangor Malaysia Finance CTS Audit & Finance Lie 28, 2024
BPA Planning Process, RLT Baarle Nassau Netherlands Finance Innovative Medicines Audit & Finance Rugp 05, 2024
Associate Director, M&A Planning & Integration East Hanover USA Finance Corporate Audit & Finance Spa 17, 2024
Assistant Manager - FC&C Hyderabad (Office) India Finance CTS Audit & Finance Spa 17, 2024
Data Analyst, Digital Finance Hyderabad (Office) India Operations Innovative Medicines Audit & Finance Spa 18, 2024
Record to Report (R2R) Specialist New Cairo Egypt Finance CTS Audit & Finance Spa 18, 2024
Record to Report (R2R) Section Head New Cairo Egypt Finance CTS Audit & Finance Spa 18, 2024
Associate, Record-to-Report Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit & Finance Bir 26, 2024
P2P Process Excellence INSURGENTES Mexico Operations CTS Audit & Finance Spa 02, 2024
Global FC&C Process Expert (Senior Manager) PIN-PCA Prague Czech Republic Finance CTS Audit & Finance Spa 03, 2024
P2P Service Delivery (SD) Lead NGSC INSURGENTES Mexico Finance CTS Audit & Finance Spa 07, 2024
Finance Control and Compliance US Manager INSURGENTES Mexico Finance CTS Audit & Finance Spa 08, 2024
General Accounting Manager INSURGENTES Mexico Finance CTS Audit & Finance Spa 09, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 42
  • › Next page

Novartis Lietuvoje

Naršyti Novartis svetainėje
  • Pacientai ir slaugytojai
  • Sveikatos priežiūros specialistai
  • Kompanijos etika
  • Naujienos
  • Karjera
Naujienos
  • Naujienų archyvas
Musų portfelis
  • Novartis vystomų produktų asortimentas
  • Novartis produktai
Kitos Novartis svetainės
  • Pasaulinė svetainė
Footer Bottom
© 2024 Novartis AG
  • Privatumo politika
  • Naudojimo sąlygos
  • Slapukai
  • Slapukų nustatymai
  • Svetainės schema
  • Svetainės prieinamumas
Novartis svetainių katalogas
Ši svetainė skirta Lietuvos gyventojams